Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiovascular consequences of sympathetic hyperactivity.

F H Leenen1

  • 1Hypertension Unit, University of Ottawa Heart Institute, Ottawa, Canada. fleenen@ohi-net.heartinst.on.ca

The Canadian Journal of Cardiology
|April 16, 1999
PubMed
Summary

Sympathetic hyperactivity worsens cardiovascular disease by affecting alpha- and beta-receptors. Targeting the central nervous system offers an alternative approach to manage sympathetic overactivity and related conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience.

Controlled clinical trials·2001
Same author

Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system.

American journal of physiology. Heart and circulatory physiology·2001
Same author

Peripheral administration of AT1 receptor blockers and pressor responses to central angiotensin II and sodium.

Canadian journal of physiology and pharmacology·2001
Same author

Enhanced sympathoexcitatory and pressor responses to central Na+ in Dahl salt-sensitive vs. -resistant rats.

American journal of physiology. Heart and circulatory physiology·2001
Same author

Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats.

Journal of Korean medical science·2001
Same author

ANG II in median preoptic nucleus and pressor responses to CSF sodium and high sodium intake in SHR.

American journal of physiology. Heart and circulatory physiology·2001

Area of Science:

  • Cardiovascular Physiology
  • Neuropharmacology

Background:

  • The sympathetic nervous system is crucial for cardiovascular homeostasis.
  • Sympathetic hyperactivity can exacerbate cardiovascular pathology and clinical events.

Purpose of the Study:

  • To explore therapeutic strategies for managing sympathetic hyperactivity.
  • To investigate the role of alpha- and beta-receptors in cardiovascular responses.
  • To examine central nervous system targets for reducing sympathetic nerve activity.

Main Methods:

  • Review of existing literature on sympathetic nervous system effects on the cardiovascular system.
  • Analysis of receptor-mediated responses (alpha- and beta-receptors) in cardiac function.
  • Evaluation of central nervous system agents (e.g., alpha2-agonists, dihydropyridines, angiotensin II receptor blockers) for their impact on sympathetic activity.

Related Experiment Videos

Main Results:

  • Both alpha- and beta-receptors mediate sympathetic effects on the heart, contributing to arrhythmias and hypertrophy.
  • Cardiac beta2-receptors influence heart rate, contractility, and norepinephrine release.
  • Central alpha2-agonists can reduce sympathetic activity but have side effects.
  • Other CNS agents like dihydropyridines and angiotensin II receptor blockers may also decrease sympathetic nerve activity.

Conclusions:

  • Optimal blockade of sympathetic hyperactivity may require combined alpha- and nonselective beta-receptor blockade.
  • Central nervous system-targeted therapies present a promising alternative for managing sympathetic overactivity.
  • Further research is needed on the therapeutic relevance of CNS effects of various drug classes, including lipophilic and hydrophilic compounds, for hypertension and heart failure.